23andMe
is part of the genetically validated axis and is progressing in clinical development | 23andMe
Company
Deck Type
Deck date
January 2022
Slide
48 of 78
Related slides by other companies
Investor Presentation
July 2021
Other recent decks by 23andMe
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io